These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6310143)

  • 21. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
    Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and antigenic domains of the matrix (M1) protein of influenza A virus.
    Ye ZP; Pal R; Fox JW; Wagner RR
    J Virol; 1987 Feb; 61(2):239-46. PubMed ID: 2433462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperation of structural proteins during late events in the life cycle of polyomavirus.
    Forstová J; Krauzewicz N; Wallace S; Street AJ; Dilworth SM; Beard S; Griffin BE
    J Virol; 1993 Mar; 67(3):1405-13. PubMed ID: 8382302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the mRNA's for the polyoma virus capsid proteins VP1, VP2, and VP3.
    Hunter T; Gibson W
    J Virol; 1978 Oct; 28(1):240-53. PubMed ID: 212604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production and characterization of monoclonal antibodies to polyomavirus major capsid protein VP1.
    Marriott SJ; Consigli RA
    J Virol; 1985 Nov; 56(2):365-72. PubMed ID: 2414462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the threonine phosphorylation sites on the polyomavirus major capsid protein VP1: relationship to the activity of middle T antigen.
    Li M; Garcea RL
    J Virol; 1994 Jan; 68(1):320-7. PubMed ID: 8254743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide.
    Cavanagh D; Sangar DV; Rowlands DJ; Brown F
    J Gen Virol; 1977 Apr; 35(1):149-58. PubMed ID: 192841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
    Saikawa T; Anderson S; Momoeda M; Kajigaya S; Young NS
    J Virol; 1993 Jun; 67(6):3004-9. PubMed ID: 7684458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial amino-terminal sequences of the polyoma nonhistone proteins VP1, VP2, and VP3 synthesized in vitro.
    Hewick RM; Mellor A; Smith AE; Waterfield MD
    J Virol; 1980 Feb; 33(2):631-6. PubMed ID: 6251238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyomavirus VP1 phosphorylation: coexpression with the VP2 capsid protein modulates VP1 phosphorylation in Sf9 insect cells.
    Li M; Delos SE; Montross L; Garcea RL
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5992-6. PubMed ID: 7597067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1.
    Moreland RB; Montross L; Garcea RL
    J Virol; 1991 Mar; 65(3):1168-76. PubMed ID: 1847446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.
    Gedvilaite A; Aleksaite E; Staniulis J; Ulrich R; Sasnauskas K
    Arch Virol; 2006 Sep; 151(9):1811-25. PubMed ID: 16575481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior.
    Freund R; Garcea RL; Sahli R; Benjamin TL
    J Virol; 1991 Jan; 65(1):350-5. PubMed ID: 1845896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyomavirus major capsid protein VP1 is modified by tyrosine sulfuration.
    Ludlow JW; Consigli RA
    J Virol; 1987 May; 61(5):1708-11. PubMed ID: 3033299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyoma virus DNA: complete nucleotide sequence of the gene which codes for polyoma virus capsid protein VP1 and overlaps the VP2/VP3 genes.
    Soeda E; Arrand JR; Griffin BE
    J Virol; 1980 Feb; 33(2):619-30. PubMed ID: 6251237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological reactivity of antisera to sodium dodecyl sulfate-derived polypeptides of polyoma virions.
    McMillen J; Consigli RA
    J Virol; 1977 Mar; 21(3):1113-20. PubMed ID: 191638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charge microheterogeneity of the major capsid protein of polyoma virus.
    Hare JD; King VL
    J Virol; 1982 Aug; 43(2):456-64. PubMed ID: 6287027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.